Kura Oncology (KURA) Short term Debt (2017 - 2025)

Kura Oncology (KURA) has 7 years of Short term Debt data on file, last reported at $4.3 million in Q3 2025.

• On a quarterly basis, Short term Debt rose 152.89% year-over-year to $4.3 million in Q3 2025; TTM through Sep 2025 was $4.3 million, a 152.89% increase from a year earlier, with the FY2024 full-year figure at $2.6 million, changed N/A from the prior year.
• Short term Debt for Q3 2025 stood at $4.3 million, up from $3.1 million in the prior quarter.
• Over the last five years, Short term Debt for KURA reached as high as $4.3 million in Q3 2025 and fell as low as $847000.0 in Q2 2024.
• Historically, Short term Debt has averaged $2.5 million across 3 years, with a median of $2.6 million in 2024.
• On a YoY basis, Short term Debt climbed as much as 267.41% in 2025 and fell as far as 152.89% in 2025.
• Year by year, Short term Debt stood at $3.0 million in 2021, then dropped by 13.1% to $2.6 million in 2024, then soared by 66.36% to $4.3 million in 2025.
• Per Business Quant data, the three most recent Short term Debt figures were $4.3 million in Q3 2025, $3.1 million in Q2 2025, and $1.9 million in Q1 2025.